• Leila Maria Da Róz, Geovanne Pedro Mauro, GicoVinicius de CarvalhoVCDepartment of Radiation Oncology, Instituto do Câncer do Estado de São Paulo (ICESP), Medical School of Sao Paulo University, São Paulo, SP, Brazil., Eduardo Weltman, de SouzaEvandro CésarECDepartment of Neurology-Discipline of Neurosurgery, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, São Paulo, SP, Brazil., Eberval Gadelha Figueiredo, and Manoel Jacobsen Teixeira.
• Department of Neurology-Discipline of Neurosurgery, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, São Paulo, SP, Brazil.
• World Neurosurg. 2023 Aug 1; 176: e415e419e415-e419.

BackgroundThe best management for AVM, particularly high-grade ones and those that have been ruptured before, is still unknown. Data from prospective data lacks support for the best approach.MethodsWe retrospectively review patients with AVM at a single institution that were treated with radiation or a combination of radiation and embolization. These patients were divided into two groups based on radiation fractionation: SRS and fSRS.ResultsOne-hundred and thirty-five (135) patients were first assessed and 121 met study criteria. Mean age at treatment was 30.5 years, and most patients were male. The groups were otherwise balanced, except for nidus size. SRS group had smaller lesions (P > 0.005). SRS correlates to better chance of nidus occlusion and lesser chance of retreatment. Complications such as radionecrosis (5%) and bleeding after nidus occlusion (1 patient) were rare.ConclusionsStereotactic radiosurgery plays an important role on the treatment of AVM. Whenever possible, SRS should be preferred. Data from prospective trials about larger and previously ruptured lesions are needed.Copyright © 2023 Elsevier Inc. All rights reserved.

15 keywords...

hide…